Orlistat Eg

Orlistat, the active ingredient in Orlistat Eg, is a lipase inhibitor presented as a oral tablet for oral use. It reduces dietary fat absorption in adults with overweight or obesity. GNH USA supplies Orlistat Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orlistat Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orlistat is used in the management of conditions that involve excess body fat and related metabolic concerns.

- Overweight and obesity: Helps ​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​  reduces ​ ​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​  fat ​ ​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​  absorption, supporting weight loss when combined with a reduced‑calorie diet. - Hyperlipidaemia associated with obesity: Contributes ​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​  to ​ ​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​  lowering ​ ​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​  blood ​ ​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​  lipid levels. - Weight‑maintenance ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​: Assists ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ in ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ maintaining ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ body ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ weight after loss. -  ​  ​ ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​ ​ ​ ​ ​ ​ ​​ ​ ​​ ​​​ ​​​ ​ ​ ​ ​​ ​​​ ​​​ ​​ ​​ ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ ​​ ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​